BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has received 510(k) clearance from the U.S. Food and Drug ...

BOULDER, Colo.--(BUSINESS WIRE)--Expanding its industry-leading vessel and tissue sealing portfolio, Covidien (NYSE:COV) received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ...

Covidien recently announced that the FDA has cleared its next generation LigaSure surgical tool. The company announced the 510(k) clearance for the LigaSure Maryland jaw open/laparoscopic ...

The approval will give Covidien access to a vast market, simultaneously widening prospects for the industry-leading vessel and tissue sealing portfolio of the company. In addition to the FDA go-ahead, ...

Covidien ($COV) won U.S. FDA 510(k) clearance for a combination laparoscopic surgical device. Known as the LigaSure laparoscopic sealer and divider, the device makes ...

Global medical device corporations Medtronic said on the 5th it will launch in Korea the surgical energy instrument "LigaSure™," which can be mounted on and used with its robotic surgery system "Hugo™ ...

Introduction: Acute appendicitis is the most common abdominal surgical emergency worldwide, with peak incidence between the second and third decades of life. Appendectomy, performed for over a century ...

Medtronic has secured EU CE mark approval for LigaSure RAS, a vessel-sealing instrument for use with the company’s Hugo robotic-assisted surgery (RAS) system. LigaSure is indicated for sealing and ...

The jury in Santa Ana found Medtronic violated antitrust law by selling ‌its LigaSure device below cost and bundling it with other products, according to an attorney for Applied Medical, which sells a ...

Medtronic has developed a portfolio of blood vessel sealing devices known as the LigaSure. By Reducing the cost of purchasing and manufacturing the device, Team 7 has designed the next step in ...